Research Notes
Evaluation of nonprescription syringe sales in San Francisco
Valerie J. Rose, DrPH, MPH; H. Fisher Raymond, MPH
J Am Pharm Assoc (2003) 2010;50:595-599. doi:10.1331/JAPhA.2010.09033


Objective  To determine the experiences, practices, and challenges associated with nonprescription syringe sales (NPSS) among pharmacists whose pharmacies were enrolled in the Disease Prevention Demonstration Project in San Francisco, CA.

Methods  Self-administered survey mailed to 69 pharmacies and interviews with pharmacists and technicians.

Results  A total of 55 of 69 pharmacies (80%) returned the survey, and eight pharmacy managers and three pharmacy technicians were interviewed in person. Of pharmacists, 72% reported none or very few problems with NPSS in the previous year, although surveys and interviews illustrated challenges associated with NPSS in terms of time management, educating patients about syringe disposal, and understanding patient preferences for syringes. Of pharmacists, 62% reported NPSS to no more than 10 to 20 patients per week and 67% collected more than 400 syringes in the previous year. One-third of pharmacists perceived that their pharmacies were located in areas where drug activity was high and that the majority of NPSS patients injected illegal drugs.

Conclusion  Access to sterile syringes is a prominent public health issue, and pharmacists can play an important role in injection drug user (IDU) education and disease prevention. This evaluation suggests that pharmacies are selling nonprescription syringes to individuals perceived to be IDUs with no major problems. Additional evaluations from health department programs are needed to demonstrate the efficacy of NPSS in California.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.


Register for a FREE limited account to benefit from personalization features such as alerts.


 California Department of Public Health, Office of AIDS. California syringe access: SB 1159 resource library. Accessed at www.syringeaccess.com, October 20,  2008.
Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.  Ann Intern Med. 2006;144:705–14.[PubMed]
 California Department of Public Health, Office of AIDS. Cumulative AIDS case data through September 30, 2008. Accessed at www.cdph.ca.gov/data/statistics/Documents/OA-2008-09-AIDSMerged.pdf, November 30,  2008.
 San Francisco Department of Public Health. Quarterly AIDS surveillance report through June, 2008. Accessed at http://sfhiv.org/files/data_reports/aids_surv_quart_rpt/qrpt0608.pdf, October 1,  2008.
Stopka TJ, Garfein RS, Ross A, Truax SR.  Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel.  J Urban Health. 2006;84:116–25.[CrossRef]
Auerbach CF.  Qualitative data: an introduction to coding and analysis. Accessed at http://site.ebrary.com.libaccess.sjlibrary.org/lib/sjsu/Doc?id=10078435&ppg=117, May 22,  2009.
 San Francisco Police Department. Crime maps. Accessed at http://gispubweb.sfgov.org/website/san_francisco_community/wizard.asp, May 15,  2009.
Vorobjob S, Uusküla A, Abel-Ollo K, et al. Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.  Harm Reduct J. 2009;6:3.[PubMed]
Moatti JP, Vlahov, D, Feroni I, et al. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and pharmacy sales in Marseille, France.  Eur Addict Res. 2001;7:40–5.[PubMed]
Rich JD, Martin EG, Macalino GE, et al. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island.  J Am Pharm Assoc. 2002;42(6 suppl 2):S58–61.
Lewis BA, Koester SK, Bush TW.  Pharmacists’ attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado.  J Am Pharm Assoc. 2002;42(6 Suppl 2):S46–51.
Taussig J, Junge B, Burris S, et al. Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia.  J Am Pharm Assoc. 2002;42(6 Suppl 2):S40–5.
Heimer R, Clair S, Teng W, et al. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990–2001.  J Urban Health. 2002;79:555–70.
Klein SJ, Harris-Valente K, Candelas AR, et al. What do pharmacists think about New York State's new nonprescription syringe sale program? Results of a survey.  J Urban Health. 2001;78:679–89.[PubMed]
Linas BP, Coffin PO, Backes G, Vlahov D. New York State pharmacists’ attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.  J Urban Health. 2000;77:768–80.[PubMed]
Farley TA, Niccolai LM, Billeter M, et al. Attitudes and practices of pharmacy managers regarding needle sales to injection drug users.  J Am Pharm Assoc. 1999;39:23–6.
Case P, Beckett G, Jones S. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.  J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(1 suppl):S94–101.[PubMed]
Gleghorn AA, Gee G, Vlahov D. Pharmacists’ attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.  J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(1 suppl):S89–93.[PubMed]
Fuller CM, Galea S, Caceres W, et al. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.  Am J Public Health. 2007;97:117–24.[PubMed]
Tesoriero JM, Battles HB, Klein SJ, et al. Expanding access to sterile syringes through pharmacies: assessment of New York's expanded syringe access program.  J Am Pharm Assoc. 2009;49:407–16.
Deibert RJ, Goldbaum G, Parker TR, et al. Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.  Am J Public Health. 2006;96:1347–58.[PubMed]
Pouget ER, Deren S, Fuller CM, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State expanded syringe access demonstration program.  J Acquir Immune Defic Syndr. 2005;39:471–7.[PubMed]
Bluthenthal RN, Malik MR, Grau LE, et al. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.  Addiction. 2004;99:1136–46.[PubMed]
Fuller CM, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.  J Am Pharm Assoc. 2002;42(6 suppl 2):S77–82.
Cotton-Oldenburg NU, Carr P, DeBoer JM, et al. The Minnesota Pharmacy Syringe Access Initiative: a successful statewide program to increase injection drug user access to sterile syringes.  J Am Pharm Assoc. 2002;42(6 Suppl 2):S21–2.
Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers: Connecticut, 1992-1993.  J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:82–9.[PubMed]
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints